W. R. Berkley is a stock, not an ETF, and it carries broad but cautious sell-side coverage. According to S&P Global data compiled by StockAnalysis, roughly 18 analysts rate the shares a consensus "Hold," with an average one-year price target near $69. MarketBeat and TipRanks report similar figures in the $69–$70 range, with an approximate low-to-high spread of $51 to $83.
That average sits below the stock's recent price near $75.42, which is why the $83 headline figure is not being presented as a consensus. Even averaging only the targets above the current price — Truist's $83, Goldman Sachs's $78, and UBS's $77 — yields about $79, less than 5% above the market. Because no usable aggregate clears a meaningful distance above the current price, the $83 objective here is best understood as the top of the analyst range: Truist Financial maintained a Buy rating and raised its target to $83 from $78 in July 2026 after a stronger-than-expected quarterly report.
Views diverge sharply. Truist and Goldman Sachs (which upgraded the stock to Buy from Neutral in June 2026) are constructive, while Wells Fargo (Underweight, $65), Barclays (Sell, $62), and Bank of America (Underperform, $69) see downside or limited upside. Morgan Stanley, Mizuho, and KBW sit in the middle with Hold ratings and targets clustered near $70. The wide $51-to-$83 range reflects genuine disagreement about the direction of commercial insurance pricing.
WRB last closed near $75.42 on October 16, 2026. Reaching $83 would require a gain of approximately 10% — a substantial move for a mature insurer and, notably, one that would take the shares to a fresh record high. The 52-week range spans roughly $62.40 to $77.45, and the stock's prior all-time high stands near $78.96.
The path toward $83 would likely require the shares first to clear the $77–$79 resistance zone and then to sustain a re-rating. Analysts estimate fiscal 2026 earnings per share (EPS) of about $4.81, implying the stock trades near a mid-teens forward price-to-earnings (P/E) multiple. For the stock to appreciate another 10% without earnings growth alone driving it, investors would generally need to assign a higher multiple — something the cautious consensus currently resists.
The shares are trading near the top of their recent range. The $77.45 52-week high and the roughly $79 all-time high form the immediate resistance zone; a decisive push above that area would be required before $83 comes into view. On the downside, the $68–$70 area has acted as support in recent months, with the 52-week low near $62.40. The $83 objective therefore represents not just a 10% advance but a break into uncharted territory above the record high.
Analyst price targets generally reflect a roughly 12-month research horizon, though individual firms set their own assumptions. Key items to watch include the Q3 2026 earnings report, commentary on commercial pricing and premium growth, the combined ratio, investment income, and any guidance on capital returns. Federal Reserve rate decisions and analyst target revisions are also likely to influence sentiment, given how tightly the stock's valuation and investment-income outlook are tied to the rate environment.
Tickeron's AI Daily Buy/Sell Signals use artificial intelligence to continuously monitor thousands of stocks and ETFs and generate Buy, Sell, or Hold signals from changing market conditions, technical behavior, and AI-driven analysis. Traders can use the tool to discover opportunities, monitor positions, and spot shifting trends more efficiently than scanning charts manually. For anyone tracking whether WRB can clear its record high, these daily signals offer a fast way to keep up with the stock's changing technical posture alongside the fundamentals discussed above.
Can WRB reach $83? The objective is grounded in the top of the current analyst range — Truist's Buy-rated target — rather than a consensus, which actually sits slightly below the stock's recent price near $75.42. Reaching $83 would require a roughly 10% advance into record-high territory, supported by recent earnings strength, rising investment income, and disciplined underwriting, but offset by softening pricing, a premium valuation, and a cautious Wall Street posture. With the analyst community deeply divided and the average target below the market, the $83 figure represents a genuine stretch scenario rather than a broadly expected outcome. Investors should watch pricing trends, the next earnings report, and analyst revisions before drawing conclusions.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
A.I.dvisor indicates that over the last year, WRB has been closely correlated with HIG. These tickers have moved in lockstep 74% of the time. This A.I.-generated data suggests there is a high statistical probability that if WRB jumps, then HIG could also see price increases.